Literature DB >> 22763886

CDC Grand Rounds: the TB/HIV syndemic.

.   

Abstract

Since Robert Koch's 1882 discovery of Mycobacterium tuberculosis, substantial progress has been made in tuberculosis (TB) control. Nevertheless, in the latter part of the 20th century, a long period of neglect of both quality program implementation and research led to persistently high TB incidence rates and failure to develop new tools to adequately address the problem. Today, most of the world continues to rely on the same diagnostic test invented by Koch approximately125 years ago and on drugs developed 40 years ago. The world now faces a situation in which approximately 160 persons die of TB each hour (1.45 million died in 2009), in which a quarter of all deaths in persons with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) (PWHA) are caused by TB, and in which the evolution of the bacteria has outpaced the evolution of its treatment to such an extent that some forms of TB are now untreatable. More recently, renewed attention has been given to reducing the global burden of TB, but much remains to be done.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22763886

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  14 in total

1.  Tuberculosis of the neuromusculoskeletal system: a review of two cases presenting as chiropractic patients.

Authors:  Ismat Kanga; John A Taylor; Craig Jacobs; Geoff Outerbridge
Journal:  J Can Chiropr Assoc       Date:  2015-03

2.  Program collaboration and service integration in the prevention and control of HIV infection, viral hepatitis, STDs, and tuberculosis in the U.S.: lessons learned from the field.

Authors:  Kevin A Fenton; Gustavo A Aquino; Hazel D Dean
Journal:  Public Health Rep       Date:  2014 Jan-Feb       Impact factor: 2.792

3.  Evaluation of pharmacokinetic interaction between PA-824 and midazolam in healthy adult subjects.

Authors:  Helen Winter; Erica Egizi; Ngozi Erondu; Ann Ginsberg; Doris J Rouse; Diana Severynse-Stevens; Elliott Pauli; Daniel Everitt
Journal:  Antimicrob Agents Chemother       Date:  2013-05-20       Impact factor: 5.191

4.  Modulation of the immune response to Mycobacterium tuberculosis during malaria/M. tuberculosis co-infection.

Authors:  R C Chukwuanukwu; C C Onyenekwe; L Martinez-Pomares; R Flynn; S Singh; G I Amilo; N R Agbakoba; J O Okoye
Journal:  Clin Exp Immunol       Date:  2016-10-21       Impact factor: 4.330

5.  Economics of United States tuberculosis airline contact investigation policies: a return on investment analysis.

Authors:  Margaret S Coleman; Karen J Marienau; Nina Marano; Suzanne M Marks; Martin S Cetron
Journal:  Travel Med Infect Dis       Date:  2013-11-08       Impact factor: 6.211

6.  HIV prevalence in the Israeli tuberculosis cohort, 1999-2011.

Authors:  Mor Zohar; Lidji Moshe; Chemtob Daniel; Cedar Noa; Grotto Itamar
Journal:  BMC Public Health       Date:  2014-10-21       Impact factor: 3.295

7.  Host iron redistribution as a risk factor for incident tuberculosis in HIV infection: an 11-year retrospective cohort study.

Authors:  Joann M McDermid; Branwen J Hennig; Marianne van der Sande; Adrian V S Hill; Hilton C Whittle; Assan Jaye; Andrew M Prentice
Journal:  BMC Infect Dis       Date:  2013-01-29       Impact factor: 3.090

8.  Tuberculosis incidence in HIV/AIDS patients in Israel, 1983-2010.

Authors:  Zohar Mor; Moshe Lidji; Noa Cedar; Itamar Grotto; Daniel Chemtob
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

9.  Comparison of trends in tuberculosis incidence among adults living with HIV and adults without HIV--Kenya, 1998-2012.

Authors:  Courtney M Yuen; Herman O Weyenga; Andrea A Kim; Timothy Malika; Hellen Muttai; Abraham Katana; Lucy Nganga; Kevin P Cain; Kevin M De Cock
Journal:  PLoS One       Date:  2014-06-17       Impact factor: 3.240

10.  Prevalence of human immunodeficiency virus infection in a cohort of tuberculosis patients at Metema Hospital, Northwest Ethiopia: a 3 years retrospective study.

Authors:  Daniel Tarekegne; Muhabaw Jemal; Tadesse Atanaw; Ashenafi Ebabu; Mengistu Endris; Feleke Moges; Belay Tessema; Tekalign Deressa
Journal:  BMC Res Notes       Date:  2016-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.